Pricing
  1. JP-listed companies
  2. JMS CO.,LTD.
  3. Financials
  4. Revenue growth (%)

JMS CO.,LTD.【JP:7702】

Market cap
¥10.7B
P/E ratio
-13.3x
JMS manufactures and sells medical devices and pharmaceuticals globally, serving healthcare markets across Asia, Europe and the Americas.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndRevenue growth (%) YoY (%)
Mar 31, 20256.8+181.07%
Mar 31, 20242.4-74.63%
Mar 31, 20239.6+830.10%
Mar 31, 20221-160.95%
Mar 31, 2021-1.7-292.05%
Mar 31, 20200.9-67.65%
Mar 31, 20192.7+60.00%
Mar 31, 20181.7-147.49%
Mar 31, 2017-3.6-188.83%
Mar 31, 20164+40.91%
Mar 31, 20152.9-70.73%
Mar 31, 20149.8+104.82%
Mar 31, 20134.8

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)